ClinicalTrials.Veeva

Menu

Validity and Reliability of the Turkish Version of the McMaster University Head and Neck Radiotherapy Questionnaire

I

Izmir Bakircay University

Status

Unknown

Conditions

Quality of Life
Head and Neck Cancer

Treatments

Other: Measurement of Quality of Life

Study type

Observational

Funder types

Other

Identifiers

NCT04269148
2018-147

Details and patient eligibility

About

More than half of the patients with head and neck cancer are locally advanced patients. Radiotherapy is the primary treatment option for many patients with stage III and stage IV diagnosed with head and neck cancer. Radiation often causes tissue reactions by increasing local symptoms of the tumor and adding new symptoms to them. The acute effects of radiation are pain and burns associated with mucosal irritations and skin irritations, the root smell of the necrotic tumor and damaged normal tissues, dry skin, skin irritation, pain and dryness of mucosal membranes, decreased appetite, loss of chewing and swallowing skills, and hoarseness. The aim of this study is to make the validity, reliability and cultural adaptation of McMaster University Head and Neck Radiotherapy Inventory in Turkish.

Full description

Although there are various surveys in the literature that evaluate the quality of life of head and neck cancer patients, apart from the "McMaster University Head and Neck Radiotherapy Questionnaire", there is no other questionnaire designed specifically for local advanced stage III and stage IV head and neck cancer and treatment of specific morbidity at a certain time. Patients in these stages often have difficulties in oral communication, nutritional disorders and loss of chewing and swallowing skills leading to dehydration, bad mouth odors, appearance problems affecting social and family life, and often significant morbidity including severe pain symptoms.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Voluntarily accepting to participate in the study
  • Patients whose native language is Turkish
  • Undergoing or receiving radiotherapy treatment
  • At least 3 weeks have passed since the beginning of radiotherapy

Exclusion criteria

  • The patient does not have sufficient functions of bone marrow, liver and kidney
  • To have scored less than 70 from Karnofsky Performance Scale

Trial design

90 participants in 1 patient group

Head and Neck Cancer patients
Description:
Turkish patients diagnosed with head and neck cancer
Treatment:
Other: Measurement of Quality of Life

Trial contacts and locations

1

Loading...

Central trial contact

Kadirhan Ozdemir, PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems